Citigroup Inc Covetrus, Inc. Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$20.69 - $20.91 $631,934 - $638,654	-30,543 Reduced 16.31%	156,748 $3.27 Million
Q2 2022 Aug 10, 2022	BUY	$13.8 - $20.82 $1.11 Million - $1.68 Million	80,581 Added 75.51%	187,291 $3.89 Million
Q1 2022 May 12, 2022	BUY	$15.96 - $18.87 $47,305 - $55,930	2,964 Added 2.86%	106,710 $1.79 Million
Q4 2021 Feb 10, 2022	SELL	$16.79 - $20.37 $3.61 Million - $4.38 Million	-215,113 Reduced 67.46%	103,746 $2.07 Million
Q3 2021 Nov 10, 2021	BUY	$18.14 - $27.03 $5.78 Million - $8.62 Million	318,859 New	318,859 $5.78 Million

72.9K

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.